Amide Formation Using In Situ Activation of Carboxylic Acids
2-Phenyl-1-(1,4-dioxa-8-azaspiro[4.5]decan-8-yl)ethanone (4): By
following protocol A, phenylacetic acid (136 mg, 1.0 mmol,
1 equiv.) and 1,4-dioxa-8-azaspiro[4.5]decane (231 μL, 1.8 mmol,
1.8 equiv.) provided the crude product, which was isolated by flash
chromatography (gradient of ethyl acetate/hexane, from 0:100 to
40:60) to give the desired product (255 mg, 97%) as a yellow oil.
Spectral data of 4 were identical with those previously reported.[22]
amine (159 μL, 1.8 mmol, 1.8 equiv.) provided the crude product,
which was isolated by flash chromatography (ethyl acetate/hexane,
40:60) to give the desired product (209 mg, 97%) as an off-white
solid. Spectral data of 10 were identical with those previously re-
ported.[24]
N-Allyl-2-phenylacetamide (11): By following protocol A, phen-
ylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and allylamine (135 μL,
1.8 mmol, 1.8 equiv.) provided the crude product, which was iso-
lated by flash chromatography (ethyl acetate/hexane, 50:50) to give
the desired product (164 mg, 94%) as a white solid. Spectral data
of 11 were identical with those previously reported.[25]
N-Benzyl-N-methyl-2-phenylacetamide (5): By following proto-
col A, phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and N-meth-
ylbenzylamine (232 μL, 1.8 mmol, 1.8 equiv.) provided the crude
product, which was isolated by flash chromatography (gradient of
ethyl acetate/hexane, from 0:100 to 40:60) to give the desired prod-
uct (225 mg, 94%) as a pale yellow oil. Signals from two rotamers
(58:42) were observed in the NMR spectra. Spectral data of 5 were
identical with those previously reported.[21]
N,2-Diphenylacetamide (12): By following protocol A, phenylacetic
acid (136 mg, 1.0 mmol, 1 equiv.) and aniline (164 μL, 1.8 mmol,
1.8 equiv.) provided the crude product, which was isolated by flash
chromatography (100% dichloromethane) to give the desired prod-
uct (201 mg, 95%) as a pale brown solid. Spectral data of 12 were
identical with those previously reported.[21]
N-(2-Hydroxyethyl)-N-methyl-2-phenylacetamide (6): By following
protocol A, phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and 2-
(methylamino)ethanol (144 μL, 1.8 mmol, 1.8 equiv.) provided the
crude product, which was isolated by flash chromatography (ethyl
acetate/hexane, 50:50 and then 100% ethyl acetate) to give the de-
sired product (120 mg, 62%) as a yellow oil. Signals from two rota-
mers (55:45) were observed in the NMR spectra. IR [attenuated
N-(Methylsulfonyl)-2-phenylacetamide (13): The title compound
was obtained by following a modified version of protocol B on a
1.0 mmol scale of phenylacetic acid. [No DBU was added, and
XtalFluor-E (1.5 equiv.) was used]. During the workup, the com-
bined organic extracts were washed with a 2% aqueous HCl solu-
tion (2ϫ). The desired product (145 mg, 68%) was isolated as a
white solid without further purification; m.p. 146–148 °C. IR
total reflectance (ATR), ZnSe): ν = 2921, 2852, 1742, 1625, 1462,
˜
1377, 1076, 728, 698 cm–1. 1H NMR (400 MHz, CDCl3, major rot-
amer): δ = 7.33–7.18 (m, 5 H), 4.87 (t, J = 5.4 Hz, 1 H), 3.73 (s, 2
H), 3.39 (t, J = 5.6 Hz, 2 H), 3.35 (t, J = 6.1 Hz, 2 H), 2.84 (s, 3
(ATR, ZnSe): ν = 3220, 1724, 1445, 1315, 1102, 939, 888, 707 cm–1.
˜
1H NMR (400 MHz, CDCl3): δ = 8.01 (s, 1 H), 7.43–7.29 (m, 3
H), 7.29–7.23 (m, 2 H), 3.70 (s, 2 H), 3.27 (s, 3 H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 169.8, 132.1, 129.7, 129.6, 128.4, 44.0,
41.6 ppm. HRMS (ESI): calcd. for C9H12NO3S [M + H]+ 214.0532;
found 214.0529.
1
H) ppm. H NMR (400 MHz, CDCl3, minor rotamer): δ = 7.33–
7.18 (m, 5 H), 4.66 (t, J = 5.4 Hz, 1 H), 3.68 (s, 2 H), 3.55–3.45
(m, 4 H), 3.02 (s, 3 H) ppm. 13C NMR (100 MHz, CDCl3): δ =
170.5 (major), 170.2 (minor), 136.3 (major), 135.9 (minor), 129.1
(major), 129.0 (minor), 128.2 (2 C), 126.2 (2 C), 58.6, 51.7, 49.9,
39.9, 39.4, 36.6, 33.3 ppm. HRMS (ESI): calcd. for C11H16NO2 [M N-(tert-Butyl)-2-phenylacetamide (14): By following protocol B,
+ H]+ 194.1176; found 194.1177.
phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and tert-butylamine
(189 μL, 1.8 mmol, 1.8 equiv.) provided the crude product, which
was isolated by flash chromatography (gradient of ethyl acetate/
hexane, from 0:100 to 40:60) to give the desired product (94 mg,
49%) as a white solid. Spectral data of 14 were identical with those
previously reported.[26]
N-Methoxy-N-methyl-2-phenylacetamide (7): The title compound
was obtained by following protocol A with slight modifications.
Phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) in ethyl acetate
(2.5 mL) gave a solution (0.4 m). To this mixture at room tempera-
ture under argon was added XtalFluor-E (230 mg, 1.0 mmol,
1 equiv.). The resulting mixture was stirred at room temperature
for 2 h. Then, it was added to a 1:1 solution of N,O-dimethyl-
hydroxylamine hydrochloride (176 mg, 1.8 mmol, 1.8 equiv.) and
N,N-diisopropylethylamine (314 μL, 1.8 mmol, 1.8 equiv.) in
EtOAc (0.5 mL). The resulting mixture was stirred at room tem-
perature for 1 h. The reaction was quenched, and the workup was
carried out as described in protocol A. Flash chromatography (gra-
dient of ethyl acetate/hexane, from 0:100 to 40:60) gave the desired
product (157 mg, 88%) as a colorless oil. Spectral data of 7 were
identical with those previously reported.[23]
N,N-Diisopropyl-2-phenylacetamide (15): By following protocol B,
phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and N,N-diisoprop-
ylamine (253 μL, 1.8 mmol, 1.8 equiv.) provided the crude product,
which was isolated by flash chromatography (gradient of ethyl acet-
ate/hexane, from 0:100 to 40:60) to give the desired product
(131 mg, 60%) as a white solid. Spectral data of 15 were identical
with those previously reported.[27]
1-Morpholino-5-phenylpentan-1-one (16): By following protocol A,
5-phenylvaleric acid (178 mg, 1.0 mmol, 1 equiv.) and morpholine
(157 μL, 1.8 mmol, 1.8 equiv.) provided the crude product, which
was isolated by flash chromatography (ethyl acetate/hexane, 50:50)
to give the desired product (241 mg, 97%) as a colorless oil. Spec-
tral data of 16 were identical with those previously reported.[28]
2-Phenyl-N-hexylacetamide (8): By following protocol A, phen-
ylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and hexylamine (238 μL,
1.8 mmol, 1.8 equiv.) provided the crude product, which was iso-
lated by flash chromatography (ethyl acetate/hexane, 30:70) to give
the desired product (218 mg, 99%) as an off-white solid. Spectral
data of 8 were identical with those previously reported.[21]
2-Methyl-1-morpholino-5-phenylpentan-1-one (17): By following
protocol A, 2-methyl-5-phenylvaleric acid (192 mg, 1.0 mmol,
1 equiv.) and morpholine (157 μL, 1.8 mmol, 1.8 equiv.) provided
the crude product, which was isolated by flash chromatography
(ethyl acetate/hexane, 50:50) to give the desired product (204 mg,
N-Benzyl-2-phenylacetamide (9): By following protocol A, phen-
ylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and benzylamine
(197 μL, 1.8 mmol, 1.8 equiv.) provided the crude product, which
was isolated by flash chromatography (ethyl acetate/hexane, 40:60)
to give the desired product (216 mg, 96%) as a white solid. Spectral
data of 9 were identical with those previously reported.[21]
78%) as a pale yellow oil. IR (ATR, ZnSe): ν = 2924, 2854, 1640,
˜
1452, 1229, 1114, 1030, 746, 699 cm–1 1H NMR (500 MHz,
.
CDCl3): δ = 7.32–7.23 (m, 2 H), 7.22–7.12 (m, 3 H), 3.71–3.50 (m,
6 H), 3.43 (s, 2 H), 2.69–2.52 (m, 3 H), 1.78–1.68 (m, 1 H), 1.66–
1.54 (m, 2 H), 1.48–1.37 (m, 1 H), 1.11 (d, J = 6.7 Hz, 3 H) ppm.
13C NMR (100 MHz, CDCl3): δ = 175.0, 142.1, 128.4, 128.3, 125.8,
N-(Furan-2-ylmethyl)-2-phenylacetamide (10): By following proto-
col A, phenylacetic acid (136 mg, 1.0 mmol, 1 equiv.) and furfuryl-
Eur. J. Org. Chem. 2013, 4325–4331
© 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4329